Trial Profile
The One-armed clinical trial of Apatinib treating for the Advanced esophageal cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Oesophageal cancer
- Focus Therapeutic Use
- 14 Nov 2016 New trial record